Literature DB >> 5307973

Acquired color vision defects secondary to retinal drug toxicity.

P Grützner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5307973

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


× No keyword cloud information.
  7 in total

Review 1.  Ocular adverse effects of neuropsychiatric agents. Incidence and management.

Authors:  T Oshika
Journal:  Drug Saf       Date:  1995-04       Impact factor: 5.606

2.  Normalization of generalized retinal function and progression of maculopathy after cessation of therapy in a case of severe hydroxychloroquine retinopathy with 19 years follow-up.

Authors:  Paul Salu; André Uvijls; Pierre van den Brande; Bart P Leroy
Journal:  Doc Ophthalmol       Date:  2010-04-16       Impact factor: 2.379

3.  A comparative study of the usefulness of color vision, photostress recovery time, and visual evoked potential tests in early detection of ocular toxicity from hydroxychloroquine.

Authors:  Javad Heravian; Massoud Saghafi; Naser Shoeibi; Samira Hassanzadeh; Mohammad Taghi Shakeri; Maria Sharepoor
Journal:  Int Ophthalmol       Date:  2011-07-12       Impact factor: 2.031

4.  The dyschromatopsia of optic neuritis: a descriptive analysis of data from the optic neuritis treatment trial.

Authors:  B Katz
Journal:  Trans Am Ophthalmol Soc       Date:  1995

Review 5.  Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates.

Authors:  Radouil Tzekov
Journal:  Doc Ophthalmol       Date:  2005-01       Impact factor: 2.379

Review 6.  Indomethacin retinopathy: case report and review.

Authors:  C M Graham; R K Blach
Journal:  Br J Ophthalmol       Date:  1988-06       Impact factor: 4.638

7.  Detecting chloroquine retinopathy: electro-oculogram versus colour vision.

Authors:  A S Neubauer; K Samari-Kermani; U Schaller; U Welge-Lübetaen; G Rudolph; T Berninger
Journal:  Br J Ophthalmol       Date:  2003-07       Impact factor: 4.638

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.